Biotechnology
Zainab S. Abbas; Ghassan M. Sulaiman; Majid S. Jabir; Hamdoon A. Mohammed; Salman A. A. Mohammed
Abstract
Galangin, a non-toxic phytochemical, is known to have a variety of therapeutic uses. This study looked into the role of inclusion complexes of galangin/β-cyclodextrin in increasing antioxidant activity over pure galangin. The role of this inclusion complex in increasing antioxidant activity in comparison ...
Read More ...
Galangin, a non-toxic phytochemical, is known to have a variety of therapeutic uses. This study looked into the role of inclusion complexes of galangin/β-cyclodextrin in increasing antioxidant activity over pure galangin. The role of this inclusion complex in increasing antioxidant activity in comparison to pure galangin. In this study, hydrogen peroxide assays were used in vitro. Galangin demonstrated concentration-dependent scavenging action in the 2-50 µg mL-1 range, with the highest level of activity possible 92.00% at 50 µg mL-1. In pure galangin, a decrease of 85.00% was observed. The ferric thiocyanate lipoperoxidation method was clarified by using galangin and galangin/β-cyclodextrin and demonstrated concentration-dependent suppress lipid peroxidation in the 2-50 µg mL-1 range, at 50 µg mL-1, the highest level of activity was 70.00%. A 60.00% decrease in pure galangin was observed. Xanthine oxidase activity using uric acid was given. The co-incubation of galangin and galangin/β-cyclodextrin inhibited xanthine oxidase activity in a concentration-dependent manner in 2-50 µg mL-1 range, at 50 µg mL-1, the highest level of activity was 90.00%. Pure galangin showed an 82.00% decrease. There were no significant differences in absolute weight of mice organs and hematological parameters between pure galangin and galangin/ β-cyclodextrin when used concentration 80 mg kg-1, compared to control group. According to the findings, galangin combined with β-cyclodextrin has excellent properties as a therapeutic agent and food supplement.
Biotechnology
Zahraa A. Kadhim; Ghassan M. Sulaiman; Ahmed M. Al-Shammari; Hamdoon A. Mohammed; Salman A. A. Mohammed
Abstract
Glioblastoma multiforme (GBM) is one of the most life-threatening types of cancer that is difficult to treat. The search for effective yet safe therapy is progressing and non-conventional therapies such as using viruses as a smart and selective agent against cancer are promising. The aim of the study ...
Read More ...
Glioblastoma multiforme (GBM) is one of the most life-threatening types of cancer that is difficult to treat. The search for effective yet safe therapy is progressing and non-conventional therapies such as using viruses as a smart and selective agent against cancer are promising. The aim of the study was the presence of a reliable method to use Newcastle disease virus (NDV) as an oncolytic agent against GBM, which attempted to propagate the NDV in laboratory experiments. Ahmed Majeed Hamza Al-Shammari-1 (AMHA1) attenuated strain of NDV was propagated in chicken embryos. The virus's tittered in Vero-slamed cells to determine the infective dose. MTT cell viability assay was used to investigate the killing effects of NDV on Ahmed-Majeed-Glioblastoma-Multiforme-2005 (AMGM5) human glioblastoma cancer cells derived from Iraqi patients. The infected cells' morphology was studied to measure the cytolytic effect of the NDV in cancer cells. Results showed that After 24 to 72 hours of inoculation, all of the chicken embryos died when the AMHA1 Iraqi NDV strain was injected. Cell viability assay showed that the NDV-AMHA1 strain has cytotoxicity at MOI of 0.1, 0.5, and 1 for 72 hours of exposure to cancer cells. The morphological analysis showed that NDV induces cell death in the infected cells with both necrotic and apoptotic features. In conclusion, the study focuses on the propagation of the oncolytic NDV as a biological agent capable of overcoming treatment resistance through infecting and replicating inside cancer.
